Futures
Access hundreds of perpetual contracts
CFD
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
CFD
U.S. stock CFD derivatives
US Stocks
Access real US stocks and ETFs
HK Stocks
Trade quality Hong Kong-listed stocks
Korean Stocks
SK Hynix
Real Korean stocks and top assets
Stock Futures
High leverage, 24/7 trading
Tokenized Stocks
Backed by real stock assets
IPO Access
Unlock full access to global stock IPOs
GUSD
3.8%
Mint GUSD for Treasury RWA yields
Stocks Activities
Trade Popular Stocks and Unlock Generous Airdrops
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
IPO Access
Unlock full access to global stock IPOs
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Promotions
AI
Gate AI
Your all-in-one conversational AI partner
Gate AI Bot
Use Gate AI directly in your social App
GateClaw
Gate Blue Lobster, ready to go
Gate for AI Agent
AI infrastructure, Gate MCP, Skills, and CLI
Gate Skills Hub
10K+ Skills
From office tasks to trading, the all-in-one skill hub makes AI even more useful.
Mixed up embryo biopsy tissue samples, Healing Reproductive Medicine says it is investigating whether there were external factors interfering.
The Heys Reproductive Medical Center experienced a suspected mix-up of embryo biopsy tissue samples. The center issued a late-night statement saying the anomaly occurred only in the processing of a small number of cell biopsy samples sent to the diagnostic center. The center has established an internal investigation team to carefully review and optimize all operational procedures.
Heys stated that in May this year, it performed preimplantation embryo cell biopsy chromosome testing for two couples receiving IVF and preimplantation genetic testing (PGT) services, and sent the samples to the Prenatal Genetic Diagnosis Center at the Prince of Wales Hospital, Chinese University of Hong Kong. The center received notifications from the diagnostic center on May 26 and June 4 that the samples were abnormal, with some samples not belonging to the patients.
Heys immediately initiated a genetic retesting process, performing new embryo cell biopsies and genetic retests for the two couples. After investigation, it was confirmed that the original embryos stored in the center’s liquid nitrogen bank were intact and safe, with no errors, mix-ups, damage, or other issues. The incident did not affect the couples involved.
Heys has proactively reported the matter to the Human Reproductive Technology Authority and is cooperating with the Department of Health and relevant authorities for a comprehensive review and investigation. The center proactively suspended accepting new cases from Monday afternoon (the 6th) until further notice.
Heys expressed deep shock over the incident, stating it will handle the matter seriously and fully cooperate with the police and relevant government departments. The investigation will include whether external factors interfered. Specific internal investigation measures include providing follow-up explanations and counseling for the two affected cases. The center has fully suspended fertility treatment services. Embryos, eggs, and sperm currently stored at the center will continue to be properly stored and will not be affected. During the suspension, the center will proactively contact all clients currently receiving reproductive services to offer free consultation, counseling, and genetic matching. For babies previously born through reproductive medical services at the center, genetic identification can be arranged if needed, and the care team will contact each family to discuss appropriate follow-up plans. For existing clients needing further treatment and services, the center will assist in transferring them to other medical centers.
Heys reiterated that after the incident, it has conducted careful genetic retesting for all PGT cases since January this year, and no abnormalities were found in the completed tests. It confirms that embryos, eggs, and sperm currently in storage will continue to be properly stored under strict standards.